2, 3-Butanediol activated disease-resistance of creeping bentgrass by inducing phytohormone and antioxidant responses
Copyright © 2018 Elsevier Masson SAS. All rights reserved.
| Veröffentlicht in: | Plant physiology and biochemistry : PPB. - 1991. - 129(2018) vom: 15. Aug., Seite 244-250 |
|---|---|
| 1. Verfasser: | |
| Weitere Verfasser: | , , , , |
| Format: | Online-Aufsatz |
| Sprache: | English |
| Veröffentlicht: |
2018
|
| Zugriff auf das übergeordnete Werk: | Plant physiology and biochemistry : PPB |
| Schlagworte: | Journal Article 2 3-Butanediol Agrostis stolonifera Induced systemic resistance Rhizoctonia solani Antioxidants Butylene Glycols Flavonoids Indoleacetic Acids mehr... |
| Zusammenfassung: | Copyright © 2018 Elsevier Masson SAS. All rights reserved. Brown patch, caused by Rhizoctonia solani, is a serious disease in Agrostis stolonifera. 2, 3-butanediol (2, 3-BD) is the major component of volatile organic compounds and was found to initiate induced systemic resistance (ISR). To investigate the induced resistance mechanism of 2, 3-BD, we examined the effects of resistance by area affected, along with changes in the content of phytohormones (Zeatin (ZT), Abscisic Acid (ABA) and Indole-3-Acetic Acid (IAA)), the activities of three phenylpropanoid metabolic enzymes (Phenylalaninammo-Nialyase (PAL), Chalcone Isomerase (CHI) and 4-Coumarate:Coenzyme A Ligase (4CL)) and the level of secondary metabolites (total phenols, flavonoid and lignin). The result showed that 2, 3-BD treatment at 250 μmoL/L had the best induction effect with the area affected decreased from 95% of the control to 55%. Compared to the controls, treatment with 250 μmoL/L 2, 3-BD induced higher levels of PAL, CHI and 4CL activity and increased total phenols, flavonoid and lignin levels. While 2, 3-BD treatment decreased the content of ZT and ABA but increased the content of IAA compared to controls. This study provides a basis for elucidating the mechanism of 2, 3-BD as a new plant disease control agent |
|---|---|
| Beschreibung: | Date Completed 12.02.2019 Date Revised 07.12.2022 published: Print-Electronic Citation Status MEDLINE |
| ISSN: | 1873-2690 |
| DOI: | 10.1016/j.plaphy.2018.06.010 |